The University of Delaware (UD) hosted the First International Symposium on Nanomedicine in Drug Delivery and Cancer Diagnosis from August 16 to 17. The conference served not just as a forum for interaction between researchers but enabled the initiation of new collaborations.
Steven Libutti of Albert Einstein College of Medicine speaks about the potential of nanomedicine
According to Professor Mary Ann McLane from UD’s Department of Medical laboratory Sciences, one such collaboration of significance to the University is NASA’s evinced interest in working with the University’s faculty to conceive a new technology for improved diagnosis. The conference also facilitated the establishment of the World Organization of Nanomedicine (WON) with an objective to provide opportunities for interaction by organizing conferences.
At the conference, Professor Steven Libutti from the Albert Einstein College of Medicine spoke about the prospects of using nanomedicine to improve the diagnosis and treatment of chronic diseases like cancer. He also emphasized the need for collaboration between researchers and clinicians for improvement in healthcare.
Kattesh Katti, director of the University of Missouri Cancer Nanotechnology was the keynote speaker and discussed his efforts towards green nanotechnology which endeavors to produce nanoparticles without harmful byproducts.
Some of the topics discussed by other speakers at the conference include nanodevices, nanomaterials, nanotoxicology, drug delivery, nanodermatology, nano-bioimaging and cancer stem cells. The conference attracted participation of attendees from eight countries apart from the U.S., namely, Germany, France, India, Brazil, Italy, Iceland, Spain and Slovenia.
The next conference on nanomedicine is scheduled to be held in 2014 in France.